Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Change in Accured Expenses (2021 - 2025)

Abeona Therapeutics has reported Change in Accured Expenses over the past 10 years, most recently at -$23000.0 for Q4 2025.

  • Quarterly results put Change in Accured Expenses at -$23000.0 for Q4 2025, down 101.35% from a year ago — trailing twelve months through Dec 2025 was -$85000.0 (down 105.64% YoY), and the annual figure for FY2025 was -$85000.0, down 105.64%.
  • Change in Accured Expenses for Q4 2025 was -$23000.0 at Abeona Therapeutics, up from -$1.4 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for ABEO hit a ceiling of $5.3 million in Q4 2021 and a floor of -$4.4 million in Q1 2022.
  • Median Change in Accured Expenses over the past 5 years was $112000.0 (2025), compared with a mean of $9473.7.
  • Biggest five-year swings in Change in Accured Expenses: surged 152.81% in 2023 and later crashed 169100.0% in 2024.
  • Abeona Therapeutics' Change in Accured Expenses stood at $5.3 million in 2021, then crashed by 80.75% to $1.0 million in 2022, then grew by 25.76% to $1.3 million in 2023, then skyrocketed by 33.46% to $1.7 million in 2024, then crashed by 101.35% to -$23000.0 in 2025.
  • The last three reported values for Change in Accured Expenses were -$23000.0 (Q4 2025), -$1.4 million (Q3 2025), and $1.2 million (Q2 2025) per Business Quant data.